Latest Blogs

Jan 16, 2019
Dr. Jean Rene V. Clemenceau Valdivia describes the shared history of the Sociedad Mexicana de Oncologia and ASCO, and the new formal partnership that will guide future collaboration between the two societies.
Jan 14, 2019
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
Jan 08, 2019
Although there’s never a bad time to make a positive commitment in your life, something about opening the calendar to January 1 feels like the right moment to set an intention.
Jan 03, 2019
Dr. Pesona Grace Lucksom's career journey has been shaped by a series of battles with hormones and their impact on women's health, and this is a fight she intends to win.
Subscribe to this column

Matthew S. Katz, MD

Matthew S. Katz, MD, is the Medical Director of Radiation Oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is former Chair of the Communications Committee for the American Society for Radiation Oncology (ASTRO) and External Advisory Board member for Mayo Clinic Center for Social Media. He serves on ASCO's Social Media Working Group, ASTRO's Education Committee, and Massachusetts Medical Society's Communications Committee. His areas of prime interest are patient education and health empowerment. Follow Dr. Katz on Twitter @subatomicdoc.

Nov 15, 2018
During my career, pathologists have always been the “doctor’s doctor.” Why can't they be the "patient's doctor" as well?
Dec 06, 2017
Only 11% of randomized trials give enough detail to practically use in clinical practice. Here are five ways we can use internet-based communication to make it easier for academic innovators to get credit for their work, and  to implement new findings for our patients.
Jul 12, 2017
Here are 10 reasons why we should look at postoperative radiation for regional melanoma.
Jul 19, 2016
Drug companies play a key role in improving cancer care, but financial toxicity for patients continues to worsen. Eternal vigilance is the price of liberty from excessive drug costs, and we have an ethical obligation to hold pharmaceutical companies accountable.
Apr 08, 2016
We have discussed risk, biology, and the importance of complete reporting. So how do we decide to actually use RNI?
Apr 04, 2016
How we report clinical trials makes interpreting their results harder. Why shouldn’t we all have more information to make better decisions for our patients?

Pages